Adherence to and Gastrointestinal Tolerability of Monthly Oral or Quarterly Intravenous Ibandronate Therapy in Women with Previous Intolerance to Oral Bisphosphonates: A 12-Month, Open-Label, Prospective Evaluation
Lewiecki, E. Michael, MD, Babbitt, Ann M., MD, Piziak, Veronica K., MD, PhD, Ozturk, Zafer E., MD, Bone, Henry G., MD
Published in Clinical therapeutics (01.04.2008)
Published in Clinical therapeutics (01.04.2008)
Get full text
Journal Article